After nearly doubling over the 20th century, the rate of increase in life expectancy has slowed considerably in the last three decades, according to a new study led by the University of Illinois Chicago.
Cedars-Sinai Cancer is advancing its commitment to diversity in research by participating in the largest-ever national study of cancer risk factors in Asian Americans. Investigators are hoping to learn why Asian Americans have disproportionately high rates of many types of cancer.
UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer’s disease.
As a kid, you may have tried to dig a hole in your backyard to reach China. Obviously, that didn’t happen. But digging out a lot of ground can be quite productive. Instead of reaching another country, the scientists, engineers, and construction workers on the LBNF-DUNE project dug up rock to enable groundbreaking science.
Mary Deynoodt has been named the Chief Executive Officer of Ochsner Baptist, located at 2700 Napolean Ave. in New Orleans.
Drug discovery is much like working a jigsaw puzzle. The chemical compounds behind drug molecules must be shaped to fit with the proteins in our bodies to produce therapeutic effects. That requirement for a meticulous fit means the creation of new drugs is extremely complex and time-consuming.
Dementia doesn’t just erode memory – it also changes behavior and mental health. A new study shows the brain’s salience network and tau protein may be involved.
The Rothman Orthopaedic Institute Foundation for Opioid Research & Education announces a symposium titled "The Next Chapter of the Opioid Epidemic in Pennsylvania: The Xylazine Crisis" to be held on November 23, 2024, from 8:30 am to 12:30 pm at the Bluemle Life Science Building at Jefferson Med in Philadelphia.
The launch window will soon open for NASA's Europa Clipper, the organization's latest mission to Jupiter's system of moons.
New experimental results suggest that sprinkling boron into a tokamak could shield the wall of the fusion vessel and prevent atoms from the wall from getting into the plasma. A new computer modeling framework shows the boron powder may only need to be sprinkled from one location. The experimental results and computer modeling framework will be presented this week at the 66th Annual Meeting of the American Physical Society Division of Plasma Physics in Atlanta.
Over the past decade, decreasing vaccination rates now threaten the huge beneficial impacts of vaccinations in the U.S. and globally. Researchers discuss the multifactorial barriers including increasing vaccine hesitancy and new clinical and public health challenges in vaccinations of U.S. adults.
A new study finds consumers are more willing to accept slower delivery from retailers when ordering products online if the retailers agree to donate to a charitable cause.
Four Jefferson Lab staff members have been named 2024 American Physical Society Fellows.
Psychiatric drugs are reported to be about 50% more effective in clinical trials funded by the drug’s manufacturer than when trials of the same drug are sponsored by other groups, new research shows.
Para cerca de um terço das pessoas com epilepsia, a medicação não consegue controlar suas convulsões. Dependendo de onde essas convulsões se originam no cérebro, a terapia a laser pode ser uma opção para adultos e crianças.
Para aproximadamente un tercio de las personas con epilepsia, la medicación no puede controlar sus convulsiones. Dependiendo de dónde se originen estas convulsiones en el cerebro, la terapia con láser puede ser una opción tanto para adultos como para niños.
روتشستر، ولاية مينيسوتا — لا تسيطر الأدوية على النوبات لما يقرب من ثلث المصابين بمرض الصرع. واعتمادًا على المناطق التي تنشأ فيها نوبات الصرع في الدماغ، يمكن أن تكون المعالجة بالليزر أحد الخيارات المتاحة للبالغين والأطفال.
Later this month Bar-Ilan University will host an international conference dedicated to the advancement of research, development and education in the field of healthy longevity.
The University of Delaware is part of a joint effort involving energy and automotive partners that has launched the first practical pilot of “vehicle-to-grid” power (V2G) set up so that industrial participants can scale it at low cost. V2G technology was invented at UD.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
